Endocrine Testing Market Size & Forecast Report,
2013 - 2024
Global Endocrine Testing Market is expected to reach USD 13.02 billion by 2024. The endocrine system is
a combined system that contains numerous glands situated throughout the body. Together with the
nervous system, the endocrine system regulates and controls several internal physical functions.
Although the nervous system uses nerve impulses as a means of control, the endocrine system uses
chemical messenger molecules called hormones. With the help of network of glands, hormones are
produced, stored, and secreted.
Thymus, adrenal glands, testes, hypothalamus, pituitary gland, ovaries, pineal gland, islet cells in the
pancreas, thyroid, and parathyroid are glands of endocrine system. The endocrine testing market is
estimated to grow at a significant CAGR of 8.0% over the future period as the scope and its applications
are rising enormously across the globe.
Endocrine testing industry is segmented based on test type, technology, end use, and region. Insulin,
estradiol (E2), cortisol, Follicle Stimulating (FSH), prolactin, Human Chorionic Gonadotropin (hCG),
Thyroid Stimulating Hormone (TSH), Luteinizing Hormone (LH), testosterone, Dehydroepiandrosterone
sulfate (DHEAS), progesterone, and other test type could be explored in endocrine testing market in the
Request Sample Copy @ https://www.millioninsights.com/industry-reports/endocrine-testing-
Thyroid Stimulating Hormone (TSH) sector accounted for the largest market share of endocrine testing
industry and is estimated to lead the overall market in the coming years. This may be because of rising
awareness regarding cardiovascular disorders and thyroid hormones levels. Moreover, insulin test is
estimated to grow at fastest pace in the coming years, as growing diabetic population.
“Global Endocrine Testing Market is expected to reach USD 13.02 billion by 2024. The
endocrine system is a combined system that contains num